Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World BioMarin Pharmaceutical, which is vying to release the most expensive drug in the world at somewhere between $2 million and $3 million a dose, announced Tuesday the departure of its chief financial officer.